RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,122 filers reported holding RAYTHEON CO in Q2 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $256,776,000 | +16.1% | 1,189,771 | +1.0% | 1.88% | +16.3% |
| Q4 2017 | $221,253,000 | +2.3% | 1,177,818 | +1.6% | 1.62% | -6.6% |
| Q3 2017 | $216,361,000 | -1.0% | 1,159,615 | -14.3% | 1.73% | -7.8% |
| Q2 2017 | $218,531,000 | +9.9% | 1,353,301 | +3.8% | 1.88% | +2.4% |
| Q1 2017 | $198,905,000 | +14.8% | 1,304,296 | +6.9% | 1.83% | -2.3% |
| Q4 2016 | $173,218,000 | +9.6% | 1,219,847 | +5.1% | 1.88% | -2.6% |
| Q3 2016 | $157,976,000 | +3.6% | 1,160,482 | +3.5% | 1.93% | -3.5% |
| Q2 2016 | $152,444,000 | +14.5% | 1,121,324 | +3.3% | 2.00% | +4.4% |
| Q1 2016 | $133,157,000 | -1.1% | 1,085,840 | +0.4% | 1.91% | -7.7% |
| Q4 2015 | $134,694,000 | +14.7% | 1,081,622 | +0.6% | 2.07% | +4.9% |
| Q3 2015 | $117,456,000 | +17.3% | 1,075,018 | +2.7% | 1.98% | +22.3% |
| Q2 2015 | $100,115,000 | -9.7% | 1,046,346 | +3.1% | 1.62% | -10.2% |
| Q1 2015 | $110,824,000 | +11.3% | 1,014,406 | +10.2% | 1.80% | +5.3% |
| Q4 2014 | $99,564,000 | +14.8% | 920,446 | +7.9% | 1.71% | +1.2% |
| Q3 2014 | $86,721,000 | +20.4% | 853,382 | +9.3% | 1.69% | +12.3% |
| Q2 2014 | $72,031,000 | +224.3% | 780,815 | +247.3% | 1.50% | +182.2% |
| Q1 2014 | $22,211,000 | +4.7% | 224,827 | -3.9% | 0.53% | -8.6% |
| Q4 2013 | $21,209,000 | +9.9% | 233,833 | -6.6% | 0.58% | -16.1% |
| Q3 2013 | $19,299,000 | -0.9% | 250,409 | -12.3% | 0.70% | -8.9% |
| Q2 2013 | $19,475,000 | – | 285,532 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |